ExaWizards Inc.

ExaWizards Inc.

4259.T
ExaWizards Inc.JP flagTokyo Stock Exchange
903.00
JPY
-34.00
- -
85.93BMarket Cap
ExaWizards Inc.
4259.T
(Tokyo Stock Exchange)

Recent

price

903.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
2026
TTM
FRC
35.43
62.6
68.28
103.08
119.06
141.83
60.84
Revenue per Share
-8.04
-1.78
-1.72
-7.5
-31.26
18.13
1.92
Basic EPS, GAAP
-14.77
-5.79
-10.29
-13.77
-4.42
8.83
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-6.87
19.91
25.5
18.95
-12.1
6.94
13.9
Book Value per Share
27
75.81
67.23
17.69
13.74
33.74
13.4
Tangible Book Value per Share
74
77
82
81
82
85
82
Basic Weighted Avg Shares
2,613
4,810
5,591
8,384
9,811
11,996
4,996
Sales/Revenue/Turnover
-19.45
-4.18
-6.76
-3.64
0.23
13.29
4.6
Operating Margin (%)
144
279
445
736
874
466
- -
Depreciation Expense
-593
-137
-141
-610
-2,576
1,533
158
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-22.68
-2.85
-2.52
-7.28
-26.26
12.78
3.16
Profit Margin (%)
2,083
5,812
5,458
3,712
3,164
4,206
3,391
Working Capital
300
310
300
2,550
1,950
1,875
2,400
LT Debt
2,383
6,632
6,619
4,983
2,538
4,749
4,631
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-7.79
-33.62
- -
- -
12.72
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
300
- -
300
LT Borrowings
2,550
- -
2,400
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
82
- -
82
Market Capitalization
46,208
28,576
26,359

Working Capital

FRC

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
5,518
- -
5,021
Cash, Cash Equivalents & STI
3,489
- -
2,993
Accounts Receivable, Net
1,851
- -
1,563
Inventories
- -
- -
- -
Total Current Liabilities
1,806
- -
1,630
Payables & Accruals
- -
- -
- -
ST Debt
300
- -
300
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
38.28%
87.12%
Free Cash Flow
- -
-61.92%
-305.22%
Net Income, GAAP
- -
84.29%
-159.51%
Sales/Revenue/Turnover
- -
37.91%
22.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,302
2,086
2,334
2,662
8,384
2025
- -
- -
- -
- -
9,811
2026
- -
- -
- -
- -
11,996

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-4.9
- -
- -
- -
-7.5
2025
- -
- -
- -
- -
-31.26
2026
- -
- -
- -
- -
18.13

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
ExaWizards Inc. (4259.T) develops and provides AI-enabled services and products for industrial innovation, digital transformation, and social issue solutions primarily in Japan. The company operates through its core exaBase platform, which offers a suite of generative AI and multi-agent AI products including exaBase Generative AI for general enterprise use; exaBase Automate for Anyone for robotic process automation; exaBase Empower for HR data analysis, recruitment, and talent allocation; exaBase Role Playing and Sales Agent for sales training and knowledge management; exaBase DX Assessment & Learning for digital skills evaluation; exaBase Studio for custom AI development; exaBase IR Assistant for investor relations; exaBase FAQ for customer support; and exaBase Generative AI for Municipalities for public sector efficiency. Additionally, its CareWiz series delivers AI-powered caregiving solutions such as CareWiz Toruto and Tayoruto to support super-aged societies by enhancing caregiver productivity and personal interaction; the company also provides consulting services for AI planning, design, development, and operations. Founded in February 2016 and headquartered at 5F Sumitomo Fudosan Mita First Building, 4-2-8 Shibaura, Minato-ku, Tokyo, ExaWizards maintains offices in Hamamatsu, Osaka, and Fukuoka, with subsidiaries including ExaMD Inc. for medical AI devices, Exa Enterprise AI Inc., Exa HomeCare Inc., STADIUM Co., Ltd., and Xware Corporation targeting sectors like healthcare, finance, manufacturing, and government. Recent developments include the September 2025 launch of exaBase Empower with a six-month free trial for HR transformation; the beta release of exaBase Automate for Anyone in September 2025 with over 100 pre-registrations; adoption of exaBase Role Playing by Shoko Chukin Bank in September 2025 and exaBase IR Assistant by Nikon in June 2025; ExaMD's partnerships with EPS Group in July and June 2025 to establish a Software as a Medical Device (SaMD) value chain for products like LocoStep gait analysis app and dementia diagnosis tools, the latter published in PLOS ONE and designated for priority review; ExaMD obtaining Type II Medical Device licenses in April 2025; and a new leadership structure announced in June 2025 under President Makoto Haruta.